A New Standard in Transplant Monitoring
Accunea is pioneering the next generation of continuous, real-time organ function monitoring to ensure that every transplant counts
THE ACCUNEA DIFFERENCE
Accunea's patent-pending microsensor array provides highly accurate continuous real-time assay of multiple established functional biomarkers including creatinine, glucose, lactate, and pyruvate.
Distributed machine learning allows the pooling of data for predictive insights into pre-implantation donor organ function and during point-of-care monitoring in the critical early post-transplantation period.
Making Critical Decisions Easier
Accunea empowers clinicians with dynamic molecular insights
Continuous information about transplant organ function at the point-of-care
AI system with population comparisons for early warnings
Sensitive and highly accurate continuous creatinine levels for calculating clearance and GFR
Extensible daily cartridge system for analysis and waste
Dynamic insights into pre- and post-implantation metabolism with glucose, lactate, pyruvate
Straightforward integration into most hospital EPR systems
Accunea is working with leading UK academics and transplant centres